P. Abbink, R. A. Larocca, . De-la, R. A. Barrera, C. A. Bricault et al., Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys, Science, vol.353, pp.1129-1132, 2016.

K. Blom, M. Braun, M. A. Ivarsson, V. D. Gonzalez, K. Falconer et al., Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector-to a memory-type response, J. Immunol, vol.190, pp.2150-2158, 2013.

I. I. Bogoch, O. J. Brady, M. U. Kraemer, M. German, M. I. Creatore et al., Anticipating the international spread of Zika virus from Brazil, Lancet, vol.387, pp.335-336, 2016.

V. M. Cao-lormeau, A. Blake, S. Mons, S. Lastere, C. Roche et al., Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study, Lancet, vol.387, pp.1531-1539, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01453407

V. M. Cao-lormeau, C. Roche, A. Teissier, E. Robin, A. L. Berry et al., Zika virus, French polynesia, South pacific, Emerg. Infect. Dis, vol.20, pp.1085-1086, 2013.

L. Dai, J. Song, X. Lu, Y. Q. Deng, A. M. Musyoki et al., Structures of the zika virus envelope protein and its complex with a flavivirus broadly protective antibody, Cell Host Microbe, vol.19, pp.696-704, 2016.

R. Das-neves-almeida, T. Racine, K. G. Magalhaes, and G. P. Kobinger, Zika Virus Vaccines: Challenges and Perspectives. Vaccines (Basel), vol.6, p.62, 2018.

W. Dejnirattisai, A. Jumnainsong, N. Onsirisakul, P. Fitton, S. Vasanawathana et al., Cross-reacting antibodies enhance dengue virus infection in humans, Science, vol.328, pp.745-748, 2010.

W. Dejnirattisai, P. Supasa, W. Wongwiwat, A. Rouvinski, G. Barba-spaeth et al., Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus, Nat. Immunol, vol.17, pp.1102-1108, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-02003950

G. W. Dick, Zika virus. II. Pathogenicity and physical properties, Trans. R. Soc. Trop. Med. Hyg, vol.46, pp.521-534, 1952.

K. A. Dowd, S. Ko, K. M. Morabito, E. S. Yang, R. S. Pelc et al., Science, vol.354, pp.237-240, 2016.

M. R. Duffy, T. Chen, W. T. Hancock, A. M. Powers, J. L. Kool et al., Federated States OF Micronesia. N. Engl. J. Med, vol.360, pp.2536-2543, 2009.

M. Dupont-rouzeyrol, L. Diancourt, E. Calvez, M. Vandenbogaert, O. O'connor et al., Zika virus evolution on the edges of the Pacific ocean, Emerg. Microb. Infect, vol.6, p.111, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01680205

A. Durbin and A. Wilder-smith, An update on Zika vaccine developments, Expert Rev. Vaccines, vol.16, pp.781-787, 2017.

E. Fernandez and M. S. Diamond, Vaccination strategies against Zika virus, Curr Opin Virol, vol.23, pp.59-67, 2017.

H. Garg, T. Mehmetoglu-gurbuz, and A. Joshi, Recent advances in zika virus vaccines, Viruses, vol.10, p.631, 2018.

M. R. Gaudinski, K. V. Houser, K. M. Morabito, Z. Hu, G. Yamshchikov et al., Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine can, Lancet, vol.391, pp.552-562, 2018.

K. A. Ghaffar, L. F. Ng, and L. Renia, Fast Tracks and Roadblocks for Zika Vaccines, Vaccines (Basel), vol.6, p.77, 2018.

E. A. Gould and T. Solomon, Pathogenic flaviviruses, Lancet, vol.371, pp.500-509, 2008.

G. D. Gromowski and A. D. Barrett, Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus, Virology, vol.366, pp.349-360, 2007.

A. Gulland, Zika virus is a global public health emergency, declares WHO, BMJ, vol.352, p.657, 2016.

S. B. Halstead, Critique of World health organization recommendation of a dengue vaccine, J. Infect. Dis, vol.214, pp.1793-1795, 2016.

S. B. Halstead, S. Mahalingam, M. A. Marovich, S. Ubol, and D. M. Mosser, Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes, Lancet Infect. Dis, vol.10, pp.712-722, 2010.

S. B. Halstead and P. K. Russell, Protective and immunological behavior of chimeric yellow fever dengue vaccine, Vaccine, vol.34, pp.1643-1647, 2016.

A. B. Kawiecki and R. C. Christofferson, Zika virus-induced antibody response enhances dengue virus serotype 2 replication in vitro, J. Infect. Dis, vol.214, pp.1357-1360, 2016.

S. Kohler, N. Bethke, M. Bothe, S. Sommerick, M. Frentsch et al., The early cellular signatures of protective immunity induced by live viral vaccination, Eur. J. Immunol, vol.42, pp.2363-2373, 2012.

V. A. Kostyuchenko, E. X. Lim, S. Zhang, G. Fibriansah, T. S. Ng et al., Structure of the thermally stable Zika virus, Nature, vol.533, pp.425-428, 2016.

G. Kuno and G. J. Chang, Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses, Arch. Virol, vol.152, pp.687-696, 2007.

R. S. Lanciotti, O. L. Kosoy, J. J. Laven, J. O. Velez, A. J. Lambert et al., Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, Emerg. Infect. Dis, vol.14, pp.1232-1239, 2007.

R. A. Larocca, P. Abbink, J. P. Peron, P. M. Zanotto, M. J. Iampietro et al., Vaccine protection against Zika virus from Brazil, Nature, vol.536, pp.474-478, 2016.

D. Li, M. Von-schaewen, X. Wang, W. Tao, Y. Zhang et al., Altered glycosylation patterns increase immunogenicity of a subunit hepatitis C virus vaccine, inducing neutralizing antibodies which confer protection in mice, J. Virol, vol.90, pp.10486-10498, 2016.

H. H. Lin, B. S. Yip, L. M. Huang, and S. C. Wu, Zika virus structural biology and progress in vaccine development, Biotechnol. Adv, vol.36, pp.47-53, 2018.

J. Liu, Y. Liu, K. Nie, S. Du, J. Qiu et al., Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes, Nature Microbiology, vol.1, p.16087, 2016.

Q. Liu, Z. Ku, Y. Cai, B. Sun, Q. Leng et al., Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins, J. Virol. Methods, vol.173, pp.115-120, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-00622889

S. Loos, H. P. Mallet, I. Leparc-goffart, V. Gauthier, T. Cardoso et al., Current Zika virus epidemiology and recent epidemics, Med. Maladies Infect, vol.44, pp.302-307, 2014.

V. Looser, B. Bruhlmann, F. Bumbak, C. Stenger, M. Costa et al., Cultivation strategies to enhance productivity of Pichia pastoris: a review, Biotechnol. Adv, vol.33, pp.1177-1193, 2015.

K. Modjarrad, L. Lin, S. L. George, K. E. Stephenson, K. H. Eckels et al., Lancet, vol.391, pp.563-571, 2018.

D. M. Morens, Antibody-dependent enhancement of infection and the pathogenesis of viral disease, Clin. Infect. Dis, vol.19, pp.500-512, 1994.

J. K. Ng, S. L. Zhang, H. C. Tan, B. Yan, J. M. Martinez et al., First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies, PLoS Pathog, vol.10, p.1004031, 2014.

N. Pardi, M. J. Hogan, R. S. Pelc, H. Muramatsu, H. Andersen et al., Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination, Nature, vol.543, pp.248-251, 2017.

T. C. Pierson, D. H. Fremont, R. J. Kuhn, and M. S. Diamond, Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development, Cell Host Microbe, vol.4, pp.229-238, 2008.

P. Qu, W. Zhang, D. Li, C. Zhang, Q. Liu et al., Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection, Antivir. Res, vol.154, pp.97-103, 2018.

S. A. Rasmussen, D. J. Jamieson, M. A. Honein, and L. R. Petersen, Zika virus and birth defects -reviewing the evidence for causality, N. Engl. J. Med, vol.374, pp.1981-1987, 2016.

F. A. Rey, K. Stiasny, and F. X. Heinz, Flavivirus structural heterogeneity: implications for cell entry, Curr Opin Virol, vol.24, pp.132-139, 2017.

W. Zhang, Antiviral Research, vol.170, p.104578, 2019.

J. M. Richner, S. Himansu, K. A. Dowd, S. L. Butler, V. Salazar et al., Modified mRNA vaccines protect against zika virus infection, Cell, vol.168, p.1110, 2017.

D. F. Robbiani, L. Bozzacco, J. R. Keeffe, R. Khouri, P. C. Olsen et al., Cell, vol.169, pp.597-609, 2017.

I. A. Rodenhuis-zybert, H. M. Van-der-schaar, J. M. Da-silva-voorham, H. Van-der-ende-metselaar, H. Y. Lei et al., Immature dengue virus: a veiled pathogen, PLoS Pathog, vol.6, 2010.

S. L. Rossi, R. B. Tesh, S. R. Azar, A. E. Muruato, K. A. Hanley et al., Characterization of a novel murine model to study zika virus, Am. J. Trop. Med. Hyg, vol.94, pp.1362-1369, 2016.

G. Sapparapu, E. Fernandez, N. Kose, C. Bin, J. M. Fox et al., Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice, Nature, vol.540, pp.443-447, 2016.

C. Shan, A. E. Muruato, B. T. Nunes, H. Luo, X. Xie et al., A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models, Nat. Med, vol.23, pp.763-767, 2017.

D. Sirohi, Z. Chen, L. Sun, T. Klose, T. C. Pierson et al., The 3.8 A resolution cryo-EM structure of Zika virus, Science, vol.352, pp.467-470, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01439629

K. Stettler, M. Beltramello, D. A. Espinosa, V. Graham, A. Cassotta et al., Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection, Science, vol.353, pp.823-826, 2016.

S. Sukupolvi-petty, S. K. Austin, W. E. Purtha, T. Oliphant, G. E. Nybakken et al., Type-and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes, J. Virol, vol.81, pp.12816-12826, 2007.

P. Tebas, C. C. Roberts, K. Muthumani, E. L. Reuschel, S. B. Kudchodkar et al., Safety and immunogenicity of an anti-zika virus DNA vaccine -preliminary report, N. Engl. J. Med, 2017.

Q. Wang, H. Yang, X. Liu, L. Dai, T. Ma et al., Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus, Sci. Transl. Med, vol.8, pp.369-179, 2016.

C. Zhang, Z. Ku, Q. Liu, X. Wang, T. Chen et al., Highyield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice, Vaccine, vol.33, pp.2335-2341, 2015.

H. Zhao, E. Fernandez, K. A. Dowd, S. D. Speer, D. J. Platt et al., Structural basis of zika virus-specific antibody protection, Cell, vol.166, pp.1016-1027, 2016.

G. Zou, Y. L. Chen, H. Dong, C. C. Lim, L. J. Yap et al., Functional analysis of two cavities in flavivirus NS5 polymerase, J. Biol. Chem, vol.286, pp.14362-14372, 2011.